Les proniosomes : avancées récentes et applications en nanomédecine
Main Article Content
Abstract
Nanotechnology has paved the way for many innovations and revolutionized the nanomedicine, especially with the emergence of niosomes and proniosomes, which are promising vesicular delivery systems for various therapeutic applications.
Proniosomes are provesicules intended to be reconstituted into niosomes, composed mainly of non-ionic surfactants and cholesterol, they allow a controlled and targeted release of active ingredients and offer advantages over niosomes, including better physical stability facilitating their transport and storage and less complex preparation methods.
This study aims to review recent advancements regarding the components, preparation and characterization methods, applications of proniosomes, as well as the factors influencing their formulation.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
A- Open Access statement and license:
1-Open Access statement:
JFMO provides immediate open access to published content in support of the idea that free access to research helps support the dissemination of knowledge and ideas in the field of medical science. All articles will be published under Creative Commons licenses.
All published data is immediate free access to the work and permits any user to read, download, copy, distribute print, search, or link to the full texts of articles.
The users of any published material in the JFMO must act in accordance with the Creative Commons Licenses CC BY-NC-ND 4.0.
2-License:
All published data is distributed following the Creative Commons Licenses CC BY-NC-ND 4.0. This license is allowing others to download the works and share them with others as long as they correctly cite the manuscript, No changes are allowed to the original manuscript and the manuscript must be used only for non for profit or non-commercial purposes.
This work is licensed under a Creative Commons AttributionNonCommercial-NoDerivatives 4.0 International License.
3-Self Archiving:
Authors are permitted and encouraged to share online their articles published in JFMO (e.g., in institutional repositories or on their website), as it can lead to productive exchanges, as well as earlier and greater citation of published work.
References
Khatoon M, Shah KU, Din FU, Shah SU, Rehman AU, Dilawar N, et al. Proniosomes derived niosomes: recentadvancements in
drugdelivery and targeting. Drug Delivery. nov 2017;24(2):56-69